Daiichi Sankyo
Caitlin Barnabo serves as the Chief of Staff for Global Oncology Medical Affairs at Daiichi Sankyo, Inc. since May 2019, with prior roles including Senior Director and Head of Project Management & Operational Excellence. Previously, Caitlin worked as an Engagement Manager at Acquis Consulting Group, where strategic consulting for global oncology medical affairs teams was a focus. Experience also includes roles as a Senior Management Analyst at Analytic Strategies, contributing to strategic projects within the Department of Defense, and as a Senior Consultant at Booz Allen Hamilton, serving high-level defense clients. Academic qualifications include a Master of Arts in European, Russian, and Eurasian Studies from The George Washington University, a Bachelor of Arts in Political Science from Boston College, a Certificate in Strategic Foresight from the University of Houston, and studies in Russian Language at Bryn Mawr College.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.